a retrospective analysis revealed that , in contrast with cmf , cyclophosphamide alone did not improve rfs significantly in subsets of patients without amenorrhea , with estrogen-receptor ( er ) negative tumors , and with tumors of low histological differentiation .
C0950521
cmf
C0010583
cyclophosphamide